Dungiven take a look at CUV's share price. It went to $45 from $25 on FDA Approval, settled back at $30 once the fanfare was over then dived to $15 through Covid now working its way back to $30. Go figure no change in the company apart from perception and market conditions. PAR's natrual behavour (for whatever reason) seems to be that it gets impacted by the sentiment of the market. Compared to say RAC which sings to its own tune.
My thought process is bank the gains on the pop, then reload at lower prices (which may never come) and if not well I enjoyed the ride.
Chart, page-785
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 21.5¢ | $288.5K | 1.279M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 130626 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |